1. Executive Summary
1.1 Situation Analysis
1.2 Market Snapshot
1.3 Key Findings
1.4 Investment & Strategic Thesis
2. Research Methodology & Scope
2.1 Scope & Market Definition
2.2 Value Basis
2.3 Market Segments
2.4 Geographic Coverage
2.5 Methodology
2.6 Sources
2.7 Author
2.8 Limitations
3. Introduction to Relationship Testing
3.1 What is Relationship Testing?
3.2 Inheritance, Chromosomes and Genes
3.3 How a Paternity Result is Calculated
3.4 Kinship Beyond the Trio
3.5 From Blood Groups to DNA
3.6 The Industry and Its Players
4. The Global Market for Paternity & Relationship Testing
4.1 Global Market Overview by Country
4.2 Global Market by Application - Overview
4.3 Global Market by Technology - Overview
4.4 Global Market by Sample Type - Overview
4.5 Global Market by Channel - Overview
4.6 Global Market by Product - Overview
5. Legal, Child Support & Court-Ordered Testing
5.1 Why Legal Testing Matters
5.2 US Child Support and IV-D Agencies
5.3 Court-Ordered Testing Worldwide
5.4 Chain of Custody and Admissibility
5.5 Paternity Fraud, Private Testing and the Law
5.6 Market Dynamics
6. Immigration, Family Reunification & Humanitarian Identification
6.1 DNA and the Family Immigration System
6.2 United States: USCIS, the State Department and ICE
6.3 United Kingdom, Canada, Australia and Europe
6.4 Refugee Family Reunion and Humanitarian Programmes
6.5 Missing Persons, Disaster Victims and Conflict
6.6 Outlook
7. Technology Landscape
7.1 From Blood Groups to Multiplex DNA
7.2 STR Multiplexes and Capillary Electrophoresis
7.3 SNP Panels, Sequencing and Prenatal Testing
7.4 Rapid DNA
7.5 Relationship Statistics and Software
7.6 Mutations, Relatedness and the Limits of Each Method
8. Laboratories, Kits, Instruments & Services
8.1 Structure of the Supply Chain
8.2 Reagent Kits and Instruments
8.3 Software, LIMS and Bioinformatics
8.4 Laboratory Business Models
8.5 Collection Networks and Outsourcing
9. Regulatory, Accreditation & Privacy Landscape
9.1 Accreditation: AABB and ISO/IEC 17025
9.2 Court Testing in the UK and Elsewhere
9.3 The US Federal Position: FDA and CLIA
9.4 State Genetic Privacy Laws
9.5 GDPR and Rules Outside the US
10. Consumer & Prenatal Testing: Channels, Pricing & Ethics
10.1 Peace-of-Mind and Legal Testing
10.2 Channels to Market
10.3 Prices by Test Type and Channel
10.4 Prenatal Paternity Testing
10.5 Ethics, Consent and Family Law
10.6 Outlook for Consumer and Prenatal Channels
11. Asia-Pacific & China Relationship Testing
11.1 Regional Overview
11.2 China
11.3 India
11.4 Southeast Asia
11.5 Japan, Korea and Australia
11.6 Outlook for Asia-Pacific
12. Deal-Making & M&A Analysis
12.1 A Consolidating Industry
12.2 Eurofins: Building a Global Relationship Testing Group
12.3 Labcorp, Forensics and the Overlap with Genealogy
12.4 Exits and Low Valuations at the Small End
12.5 Government Contracts as Deals
12.6 Deal Outlook
13. Recent Developments
13.1 USCIS Tells Officers to Suggest DNA Testing When Relationships Are Unproven
13.2 DHS Proposes Rule Allowing USCIS to Require DNA Evidence
13.3 ICE Expands Rapid DNA Testing of Family Units Through SNA International
13.4 23andMe Bankruptcy Plan Confirmed, Company Wound Down as Chrome Holding
13.5 42 States Settle With 23andMe Over 2023 Data Breach
13.6 Othram Acquires Sorenson Forensics
13.7 FBI Approves Rapid DNA Crime Scene Profiles for CODIS Searches
13.8 Wave of US State Genetic Privacy Laws
13.9 India's Supreme Court Upholds Court-Ordered DNA Paternity Test
13.10 UK High Court Upholds Suspension of Refugee Family Reunion
14. Operations, Chain of Custody & Supply Chain
14.1 The Testing Workflow
14.2 Collection, Identity and Chain of Custody
14.3 Laboratory Automation and Staffing
14.4 Quality, Accreditation and Proficiency Testing
14.5 Reagent and Instrument Supply Chain
14.6 Operational Outlook
15. Competitive Landscape
15.1 Structure of Competition
15.2 Tiers of Players
15.3 Leading Players by Role
15.4 Competitive Dynamics
15.5 Consolidation and Recent Deals
15.6 Outlook for Competition
16. SWOT, Porter's Five Forces & Investment Risk Analysis
16.1 SWOT Analysis
16.2 Porter's Five Forces
16.3 Investment Risk Analysis
17. Strategic Recommendations
17.1 Guidance for Executives, Marketing, Sales and Business Development
17.2 Guidance for Management Consultants and Investment Advisors
18. Market Forecast by Application, 2026-2031
18.1 Legal & Court-Ordered
18.2 Immigration & Family Reunification
18.3 Prenatal Paternity
18.4 Consumer Peace-of-Mind
18.5 Kinship, Missing Persons & Identification
18.6 Clinical & Other
19. Market Forecast by Technology, 2026-2031
19.1 STR / Capillary Electrophoresis
19.2 SNP Arrays & Targeted SNP Panels
19.3 NGS / Massively Parallel Sequencing
19.4 Rapid DNA
19.5 Other
20. Market Forecast by Sample Type, 2026-2031
20.1 Postnatal Buccal & Blood
20.2 Non-invasive Prenatal (cfDNA)
20.3 Invasive Prenatal (CVS / Amniocentesis)
20.4 Non-standard & Post-mortem Samples
21. Market Forecast by Channel, 2026-2031
21.1 Government & Court Contracts
21.2 Accredited Lab via Clinics & Collection Sites
21.3 Direct-to-Consumer Online
21.4 Retail & Pharmacy Kits
22. Market Forecast by Product, 2026-2031
22.1 Testing Services
22.2 Reagents & Kits
22.3 Instruments
22.4 Software & Bioinformatics
23. Company Profiles
23.1 23andMe Research Institute (TTAM)
23.2 AGCU ScienTech
23.3 AlphaBiolabs
23.4 Ancestry
23.5 ANDE Corporation
23.6 Any Lab Test Now
23.7 BGI Genomics
23.8 Bode Technology
23.9 Bureau Veritas
23.10 Canadian DNA Services
23.11 Cellmark (Orchid Cellmark, a Eurofins company)
23.12 DNA Diagnostics Center (DDC)
23.13 DNA Forensics Laboratory (India)
23.14 DNA Solutions, Inc.
23.15 DNA·VIEW (Charles Brenner)
23.16 Dubai Police General Department of Forensic Science and Criminology
23.17 Endeavor DNA (EasyDNA)
23.18 Eurofins Medigenomix Forensik (Eurofins Forensik)
23.19 Eurofins Scientific
23.20 Gene by Gene / FamilyTreeDNA (myDNA)
23.21 Genex Diagnostics (Genetrack Biolabs)
23.22 Genomia
23.23 Grupo Fleury (Hermes Pardini)
23.24 Health Street
23.25 Humatrix AG
23.26 Identilab
23.27 Illumina
23.28 International Biosciences (IB DNA)
23.29 Labcorp
23.30 Laboratorio Genes (Colombia)
23.31 MBN Clinical Laboratories
23.32 MGI Tech
23.33 Microread Genetics
23.34 Natera
23.35 NimaGen
23.36 Othram
23.37 Parabon NanoLabs
23.38 Promega
23.39 Qiagen
23.40 Quest Diagnostics
23.41 SMART Research (Bonaparte)
23.42 SNA International
23.43 St. Luke's Medical Center (Philippines)
23.44 STRmix (PHF Science)
23.45 Synlab
23.46 Thermo Fisher Scientific
23.47 Viaguard Accu-Metrics
24. Appendix
24.1 Abbreviations
24.2 Developments Archive
24.3 Report Limitations Restated
List of Tables
Table 1 Key Market Indicators (constant 2026 US$)
Table 2 Global Market by Segment, 2026 and 2031 (US$ millions, constant 2026 dollars)
Table 3 Main Types of Relationship Test
Table 4 Paternity Index and Probability of Paternity
Table 5 Milestones in Relationship Testing
Table 6 Global Market by Country
Table 7 Global Market by Application
Table 8 Global Market by Technology
Table 9 Global Market by Sample Type
Table 10 Global Market by Channel
Table 11 Global Market by Product
Table 12 Legal Frameworks for Paternity Testing, Selected Countries
Table 13 US Federal Use of Relationship Testing
Table 14 Immigration DNA Testing Rules, Selected Countries
Table 15 Main Relationship Testing Technologies Compared
Table 16 Selected Kits and Instruments Used in Relationship Testing
Table 17 Selected Relationship Testing Service Providers
Table 18 Accreditation Bodies and Standards in Relationship Testing
Table 19 US State Genetic Privacy Laws Enacted or Vetoed in 2026
Table 20 Examples of Published Relationship Test Prices by Channel
Table 21 Asia-Pacific Relationship Testing Frameworks (Summary)
Table 22 Selected Relationship and Forensic DNA Testing Deals
Table 23 Typical Stages and Controls in a Legal Relationship Test
Table 24 Competitive Structure by Application
Table 25 Tiers of Relationship Testing Service Providers
Table 26 Leading Legal and Immigration Testing Laboratories
Table 27 Selected Direct-to-Consumer Relationship Testing Brands
Table 28 Leading Kit and Instrument Suppliers
Table 29 Leading Software Providers
Table 30 SWOT Analysis - Strengths and Weaknesses
Table 31 SWOT Analysis - Opportunities and Threats
Table 32 Porter's Five Forces Ratings
Table 33 Investment Risk Matrix
Table 34 Selected Growth Opportunities
Table 35 Legal & Court-Ordered by Country
Table 36 Immigration & Family Reunification by Country
Table 37 Prenatal Paternity by Country
Table 38 Consumer Peace-of-Mind by Country
Table 39 Kinship, Missing Persons & Identification by Country
Table 40 Clinical & Other by Country
Table 41 STR / Capillary Electrophoresis by Country
Table 42 SNP Arrays & Targeted SNP Panels by Country
Table 43 NGS / Massively Parallel Sequencing by Country
Table 44 Rapid DNA by Country
Table 45 Other by Country
Table 46 Postnatal Buccal & Blood by Country
Table 47 Non-invasive Prenatal (cfDNA) by Country
Table 48 Invasive Prenatal (CVS / Amniocentesis) by Country
Table 49 Non-standard & Post-mortem Samples by Country
Table 50 Government & Court Contracts by Country
Table 51 Accredited Lab via Clinics & Collection Sites by Country
Table 52 Direct-to-Consumer Online by Country
Table 53 Retail & Pharmacy Kits by Country
Table 54 Testing Services by Country
Table 55 Reagents & Kits by Country
Table 56 Instruments by Country
Table 57 Software & Bioinformatics by Country
List of Figures
Figure 1 Key Graphic - Beyond the STR Ladder: Relationship Testing Market by Technology, 2026 vs 2031
Figure 2 DNA Strands and Chromosomes
Figure 3 Karyogram of Human Chromosomes
Figure 4 Global Market Pareto Chart
Figure 5 Global Market by Application - Base vs. Final
Figure 6 Global Market by Application Base Year
Figure 7 Global Market by Application End Year
Figure 8 Application Share by Year
Figure 9 Application Segments Growth
Figure 10 Global Market by Technology - Base vs. Final
Figure 11 Global Market by Technology Base Year
Figure 12 Global Market by Technology End Year
Figure 13 Technology Share by Year
Figure 14 Technology Segments Growth
Figure 15 Global Market by Sample Type - Base vs. Final
Figure 16 Global Market by Sample Type Base Year
Figure 17 Global Market by Sample Type End Year
Figure 18 Sample Type Share by Year
Figure 19 Sample Type Segments Growth
Figure 20 Global Market by Channel - Base vs. Final
Figure 21 Global Market by Channel Base Year
Figure 22 Global Market by Channel End Year
Figure 23 Channel Share by Year
Figure 24 Channel Segments Growth
Figure 25 Global Market by Product - Base vs. Final
Figure 26 Global Market by Product Base Year
Figure 27 Global Market by Product End Year
Figure 28 Product Share by Year
Figure 29 Product Segments Growth
Figure 30 Legal & Court-Ordered Growth
Figure 31 Immigration & Family Reunification Growth
Figure 32 Prenatal Paternity Growth
Figure 33 Consumer Peace-of-Mind Growth
Figure 34 Kinship, Missing Persons & Identification Growth
Figure 35 Clinical & Other Growth
Figure 36 STR / Capillary Electrophoresis Growth
Figure 37 SNP Arrays & Targeted SNP Panels Growth
Figure 38 NGS / Massively Parallel Sequencing Growth
Figure 39 Rapid DNA Growth
Figure 40 Other Growth
Figure 41 Postnatal Buccal & Blood Growth
Figure 42 Non-invasive Prenatal (cfDNA) Growth
Figure 43 Invasive Prenatal (CVS / Amniocentesis) Growth
Figure 44 Non-standard & Post-mortem Samples Growth
Figure 45 Government & Court Contracts Growth
Figure 46 Accredited Lab via Clinics & Collection Sites Growth
Figure 47 Direct-to-Consumer Online Growth
Figure 48 Retail & Pharmacy Kits Growth
Figure 49 Testing Services Growth
Figure 50 Reagents & Kits Growth
Figure 51 Instruments Growth
Figure 52 Software & Bioinformatics Growth